[A case of preauricular and cervical lymphadenitis due to Mycobacterium intracellulare].

H. Saito,H. Tasaka,T. Mochizuki,M. Kitano,S. Osasa,T. Yamura,S. Oda

Abstract:

What problem does this paper attempt to address?

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

XU Mei-Fen,HE Yi-Qun,GUAN Min-Xin

DOI: https://doi.org/10.13865/j.cnki.cjbmb.2013.12.002

2013-01-01

Abstract:Mitochondria are dynamic organelles that continually undergo fusion and fission.At steady state,there is a balance between mitochondrial fusion and fission,the balance is regulated by mitofusin1/2(Mfn1/2),optic atrophy 1(OPA1) and dynamin-related protein1(Drp1).Mfn1/2 mediate outer membrane fusion,and OPA1subsequently mediates inner membrane fusion.These proteins are regulated by proteolysis and ubiquitination.Drp1 involves in mitochondrial fission,several different posttranslational modifications,including phosphorylation,ubiquitination,sumoylation,and s-nitrosylation of Drp1 regulate its interaction with mitochondria.In neurons,the dynamic of mitochondrial fusion and fission are important for the nerve endings of long-distance transportation and the average energy distribution,so the unbalance of mitochondrial fusion and fission is one of the most frequent causes for neurodegenerative diseases.In terms of fusion,heterozygous mutations in Mfn2 and OPA1 cause autosomal dominant axonal Charcot-Marie-Tooth type 2A(CMT2A) and autosomal dominant optic atrophy(ADOA),respectively.In terms of fission,a mutation in Drp1 has been linked to neonatal lethality with multisystem failure.
Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging

Vladimir S. Sukhorukov,Tatiana I. Baranich,Anna V. Egorova,Anastasia V. Akateva,Kseniia M. Okulova,Maria S. Ryabova,Krisitina A. Skvortsova,Oscar V. Dmitriev,Natalia M. Mudzhiri,Dmitry N. Voronkov,Sergey N. Illarioshkin

DOI: https://doi.org/10.3390/ijms252312855

IF: 5.6

2024-11-30

International Journal of Molecular Sciences

Abstract:Mitochondrial dynamics significantly play a major role in the pathogenesis of neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease. The dysregulation of mitochondrial biogenesis and function, characterized by impaired fission and fusion processes mediated by a number of proteins, in particular, Drp1, Mfn1, Mfn2, Opa1, and PGC-1α, contributes to neuronal vulnerability and degeneration. Insufficient mitophagy and disrupted mitochondrial transport exacerbate oxidative stress and neurotoxicity. Emerging therapeutic strategies that target mitochondrial dynamics, including various pharmacological agents, demonstrate potential for restoring mitochondrial balance and enhancing neuroprotection. This growing body of research underscores the importance of mitochondrial health in developing effective interventions for neurodegenerative conditions. This review highlights well-established links between the disruption of mitochondrial dynamics and the development of neurodegenerative processes. We also discuss different therapeutic strategies that target mitochondrial function in neurons that have been proposed as perspective neuroprotective treatments.

biochemistry & molecular biology,chemistry, multidisciplinary
Rapid induction of hypothalamic iodothyronine deiodinase expression by photoperiod and melatonin in juvenile Siberian hamsters (Phodopus sungorus).

B. Prendergast,L. Pyter,August Kampf-Lassin,Priyesh N. Patel,T. J. Stevenson

DOI: https://doi.org/10.1210/en.2012-1990

IF: 5.051

2013-01-07

Endocrinology

Abstract:Production of T(3) in the mediobasal hypothalamus is critical for regulation of seasonal reproductive physiology. Type 2 iodothyronine deiodinase (DIO2) and DIO3 enzymes catalyze the prohormone T(4) into biologically-active T(3) and biologically-inactive rT(3), respectively. In several seasonally-breeding vertebrates, DIO2 and DIO3 expression is implicated in photoperiod signal transduction in adulthood. These experiments tested the hypothesis that juvenile Siberian hamsters, which are highly responsive to photoperiod at weaning (postnatal day [PND]18), exhibit rapid and sustained changes in hypothalamic dio3 mRNA expression during photoperiod-induced and photoperiod-inhibited puberty. Hypothalamic dio2 and dio3 expression was measured via quantitative PCR in hamsters born and reared in a long-day photoperiod (15L:9D) and weaned on PND18 into short-day photoperiods (9L:15D). In SD males, hypothalamic dio3 mRNA was elevated 2.5-fold within 3 days (PND21) and continued to increase (>20-fold) through PND32; changes in dio3 mRNA preceded inhibition of gonadotropin (FSH) secretion and gonadal regression in SD. Females exhibited comparable dio3 responses to SD. In LD males, dio3 remained low and invariant from PND18-PND32. In contrast, dio2 mRNA rose conspicuously on PND21, independent of photoperiod, returning to basal levels thereafter. In LD, a single afternoon melatonin (MEL) injection on PND18 or PND20 was sufficient to increase hypothalamic dio3 mRNA, and dio3 increased in proportion to the number of successive days of MEL treatment. SD photoperiods and MEL exert rapid, sustained, and additive effects on hypothalamic dio3 mRNA, which may play a central role in inhibiting maturation of the peripubertal hypothalamo-pituitary-gonadal axis.
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment

Mojtaba Golpich,Elham Amini,Zahurin Mohamed,Raymond Azman Ali,Norlinah Mohamed Ibrahim,Abolhassan Ahmadiani

DOI: https://doi.org/10.1111/cns.12655

2016-11-22

Abstract:Neurodegenerative diseases are a heterogeneous group of disorders that are incurable and characterized by the progressive degeneration of the function and structure of the central nervous system (CNS) for reasons that are not yet understood. Neurodegeneration is the umbrella term for the progressive death of nerve cells and loss of brain tissue. Because of their high energy requirements, neurons are especially vulnerable to injury and death from dysfunctional mitochondria. Widespread damage to mitochondria causes cells to die because they can no longer produce enough energy. Several lines of pathological and physiological evidence reveal that impaired mitochondrial function and dynamics play crucial roles in aging and pathogenesis of neurodegenerative diseases. As mitochondria are the major intracellular organelles that regulate both cell survival and death, they are highly considered as a potential target for pharmacological-based therapies. The purpose of this review was to present the current status of our knowledge and understanding of the involvement of mitochondrial dysfunction in pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) and the importance of mitochondrial biogenesis as a potential novel therapeutic target for their treatment. Likewise, we highlight a concise overview of the key roles of mitochondrial electron transport chain (ETC.) complexes as well as mitochondrial biogenesis regulators regarding those diseases.

pharmacology & pharmacy,neurosciences
Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases

Abdul Aziz Mohamed Yusoff,Siti Zulaikha Nashwa Mohd Khair

DOI: https://doi.org/10.1515/revneuro-2024-0080

2024-08-20

Abstract:Neurodegenerative diseases represent a significant challenge to modern medicine, with their complex etiology and progressive nature posing hurdles to effective treatment strategies. Among the various contributing factors, mitochondrial dysfunction has emerged as a pivotal player in the pathogenesis of several neurodegenerative disorders. This review paper provides a comprehensive overview of how mitochondrial impairment contributes to the development of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, driven by bioenergetic defects, biogenesis impairment, alterations in mitochondrial dynamics (such as fusion or fission), disruptions in calcium buffering, lipid metabolism dysregulation and mitophagy dysfunction. It also covers current therapeutic interventions targeting mitochondrial dysfunction in these diseases.
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease

Afzal Misrani,Sidra Tabassum,Li Yang

DOI: https://doi.org/10.3389/fnagi.2021.617588

IF: 4.8

2021-02-18

Frontiers in Aging Neuroscience

Abstract:Mitochondria play a pivotal role in bioenergetics and respiratory functions, which are essential for the numerous biochemical processes underpinning cell viability. Mitochondrial morphology changes rapidly in response to external insults and changes in metabolic status via fission and fusion processes (so-called mitochondrial dynamics) that maintain mitochondrial quality and homeostasis. Damaged mitochondria are removed by a process known as mitophagy, which involves their degradation by a specific autophagosomal pathway. Over the last few years, remarkable efforts have been made to investigate the impact on the pathogenesis of Alzheimer’s disease (AD) of various forms of mitochondrial dysfunction, such as excessive reactive oxygen species (ROS) production, mitochondrial Ca 2+ dyshomeostasis, loss of ATP, and defects in mitochondrial dynamics and transport, and mitophagy. Recent research suggests that restoration of mitochondrial function by physical exercise, an antioxidant diet, or therapeutic approaches can delay the onset and slow the progression of AD. In this review, we focus on recent progress that highlights the crucial role of alterations in mitochondrial function and oxidative stress in the pathogenesis of AD, emphasizing a framework of existing and potential therapeutic approaches.

neurosciences,geriatrics & gerontology,gerontology
Species differences in the changes in heart rate and T-wave amplitude after autonomic blockade in Thoroughbred horses, ponies, cows, pigs, goats and chickens.

K. Matsui,S. Sugano

DOI: https://doi.org/10.1292/JVMS1939.49.637

1987-08-01

Abstract:Using Thoroughbred horses, ponies, Holstein cows, pigs, goats and chickens, the effects of atropine and/or propranolol on heart rate (HR) and T-wave amplitude (TWA) on ECG were examined. HR increased significantly in all animal species after the administration of atropine, and decreased in the pig, goat and chicken after the administration of propranolol. Parasympathetic predominance, estimated from the changes in HR induced by the autonomic blockers, was in the order of Thoroughbred horse > pony > cow > goat whereas the sympathetic predominance was in the order of chicken > pig. The positive ingredient in TWA was increased significantly in the Thoroughbred horse, pony, pig, and goat by atropine whereas decreased only in the pig by propranolol.
Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology

Divya Sri Kathiresan,Rubadevi Balasubramani,Kamalesh Marudhachalam,Piyush Jaiswal,Nivedha Ramesh,Suruthi Gunna Sureshbabu,Vinayaga Moorthi Puthamohan,Murali Vijayan

DOI: https://doi.org/10.1007/s12035-024-04469-x

2024-09-13

Abstract:Mitochondria, essential organelles responsible for cellular energy production, emerge as a key factor in the pathogenesis of neurodegenerative disorders. This review explores advancements in mitochondrial biology studies that highlight the pivotal connection between mitochondrial dysfunctions and neurological conditions such as Alzheimer's, Parkinson's, Huntington's, ischemic stroke, and vascular dementia. Mitochondrial DNA mutations, impaired dynamics, and disruptions in the ETC contribute to compromised energy production and heightened oxidative stress. These factors, in turn, lead to neuronal damage and cell death. Recent research has unveiled potential therapeutic strategies targeting mitochondrial dysfunction, including mitochondria targeted therapies and antioxidants. Furthermore, the identification of reliable biomarkers for assessing mitochondrial dysfunction opens new avenues for early diagnosis and monitoring of disease progression. By delving into these advancements, this review underscores the significance of understanding mitochondrial biology in unraveling the mechanisms underlying neurodegenerative disorders. It lays the groundwork for developing targeted treatments to combat these devastating neurological conditions.
Alleviating Neurodegenerative Diseases Associated with Mitochondrial Defects by Therapeutic Biomolecules

Tanmoy Roy,Swarupanjali Padhi,Rupa Mazumder,Chandana Majee,Saumya Das,Monika Monika,Rashmi Mishra,Bhupinder Kapoor

DOI: https://doi.org/10.2174/0115680266299148240329062647

2024-04-05

Current Topics in Medicinal Chemistry

Abstract:Abstract: Neurodegenerative diseases are emerging as a global health concern in the current sce-nario, and their association with mitochondrial defects has been a potential area of research. Mi-tochondria, one of the essential organelles of the cell, serve as the cell's powerhouse, producing energy and ensuring cellular health. Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis, and Pelizaeus-Merzbacher disease have been found to be primarily triggered by mitochondrial malfunction. One of the key byproducts of mitochondrial respiration, reactive oxygen species, also contributes significantly to mitochondrial DNA muta-tions that eventually cause mitochondrial breakdown. This review paper comprehensively examines the potential of therapeutic biomolecules, specifi-cally mitochondria-specific antioxidants, in mitigating the impact of mitochondrial defects on neurodegenerative diseases. It provides a detailed analysis of the mechanisms involved in mito-chondrial dysfunction, the potential therapeutic targets of these biomolecules, and their structure-activity relationship information are also discussed in this review. Various research articles and publications were used extensively in compiling the data, and the structures of biomolecules were prepared using software such as ChemDraw and ChemSketch. Crucial elements triggering mitochondrial abnormalities were identified and a tabular compilation of bioactive antioxidant compounds along with their therapeutic targets, was presented. Mitochondria-specific antioxidant therapy is an innovative and promising strategy for the man-agement of neurodegenerative diseases associated with mitochondrial defects. This review pro-vides a thorough summary of the current state of research and promising avenues of research and development in this field, emphasizing the importance of further investigations and clinical trials to elucidate their therapeutic benefits.

chemistry, medicinal
Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases

Athanasios Alexiou,Bilal Nizami,Faez Iqbal Khan,Georgia Soursou,Charalampos Vairaktarakis,Stylianos Chatzichronis,Vasilis Tsiamis,Vasileios Manztavinos,Nagendra Sastry Yarla,Ghulam Md Ashraf

DOI: https://doi.org/10.2174/1389203718666170810150151

2018-07-17

Current Protein and Peptide Science

Abstract:Disruptions in the regulation of mitochondrial dynamics and the occurrence of proteins misfolding lead to neuronal death, resulting in Age-related Dementia and Neurodegenerative diseases as well as Frailty. Functional, neurophysiologic and biochemical alterations within the mitochondrial populations can reveal deficits in brain energy metabolism resulting in Mild Cognitive Impairment, abnormal neural development, autonomic dysfunction and other mitochondrial disorders. Additionally, in cases of Alzheimer's disease or Parkinson's disease, a significant number of proteins seem to form unordered and problematic structures, leading through unknown mechanisms to pathological conditions. While the proteins structure prediction problem is still an open challenge regarding its complexity, several features associated with the correlations of misfolding proteins and Neurodegeneration are discussed in the present study and a computational analysis for the proteins Amyloid Beta, Tau, α-Synuclein, Parkin, Pink1, MFN1, MFN1, OPA1, and DNM1L is also presented.

biochemistry & molecular biology
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets

Yati Sharma,Jeetendra Kumar Gupta,M. Arockia Babu,Sumitra Singh,Rakesh K. Sindhu

DOI: https://doi.org/10.1007/s12031-024-02269-5

2024-10-30

Journal of Molecular Neuroscience

Abstract:Mitochondrion is an important organelle present in our cells responsible for meeting energy requirements. All higher organisms rely on efficient mitochondrial bioenergetic machinery to sustain life. No other respiratory process can produce as much power as generated by mitochondria in the form of ATPs. This review is written in order to get an insight into the magnificent working of mitochondrion and its implications in cellular homeostasis, bioenergetics, redox, calcium signaling, and cell death. However, if this machinery gets faulty, it may lead to several disease states. Mitochondrial dysfunctioning is of growing concern today as it is seen in the pathogenesis of several diseases which includes neurodegenerative disorders, cardiovascular disorders, diabetes mellitus, skeletal muscle defects, liver diseases, and so on. To cover all these aspects is beyond the scope of this article; hence, our study is restricted to neurodegenerative disorders only. Moreover, faulty functioning of this organelle can be one of the causes of early ageing in individuals. This review emphasizes mutations in the mitochondrial DNA, defects in oxidative phosphorylation, generation of ROS, and apoptosis. Researchers have looked into new approaches that might be able to control mitochondrial failure and show a lot of promise as treatments.

biochemistry & molecular biology,neurosciences
Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Pedro Norat,Sauson Soldozy,Jennifer D Sokolowski,Catherine M Gorick,Jeyan S Kumar,Youngrok Chae,Kaan Yağmurlu,Francesco Prada,Melanie Walker,Michael R Levitt,Richard J Price,Petr Tvrdik,M Yashar S Kalani

DOI: https://doi.org/10.1038/s41536-020-00107-x

2020-11-23

Abstract:Mitochondria are fundamental for metabolic homeostasis in all multicellular eukaryotes. In the nervous system, mitochondria-generated adenosine triphosphate (ATP) is required to establish appropriate electrochemical gradients and reliable synaptic transmission. Notably, several mitochondrial defects have been identified in central nervous system disorders. Membrane leakage and electrolyte imbalances, pro-apoptotic pathway activation, and mitophagy are among the mechanisms implicated in the pathogenesis of neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's disease, as well as ischemic stroke. In this review, we summarize mitochondrial pathways that contribute to disease progression. Further, we discuss pathological states that damaged mitochondria impose on normal nervous system processes and explore new therapeutic approaches to mitochondrial diseases.
Mitochondrial Dynamics: A Key Role in Neurodegeneration and a Potential Target for Neurodegenerative Disease

Danying Yang,Jun Ying,Xifeng Wang,Tiancheng Zhao,Sungtae Yoon,Yang Fang,Qingcui Zheng,Xing Liu,Wen Yu,Fuzhou Hua

DOI: https://doi.org/10.3389/fnins.2021.654785

IF: 4.3

2021-04-12

Frontiers in Neuroscience

Abstract:In neurodegenerative diseases, neurodegeneration has been related to several mitochondrial dynamics imbalances such as excessive fragmentation of mitochondria, impaired mitophagy, and blocked mitochondria mitochondrial transport in axons. Mitochondria are dynamic organelles, and essential for energy conversion, neuron survival, and cell death. As mitochondrial dynamics have a significant influence on homeostasis, in this review, we mainly discuss the role of mitochondrial dynamics in several neurodegenerative diseases. There is evidence that several mitochondrial dynamics-associated proteins, as well as related pathways, have roles in the pathological process of neurodegenerative diseases with an impact on mitochondrial functions and metabolism. However, specific pathological mechanisms need to be better understood in order to propose new therapeutic strategies targeting mitochondrial dynamics that have shown promise in recent studies.

neurosciences
Clinical and morphometric observations on prostate cancer.

T. Stamey

Abstract:
Targeting mitochondrial dysfunction to salvage cellular senescence for managing neurodegeneration

Komal Sharma,Joyobrata Sarkar,Anchal Trisal,Rishika Ghosh,Anubhuti Dixit,Abhishek Kumar Singh

DOI: https://doi.org/10.1016/bs.apcsb.2023.02.016

Abstract:Aging is an inevitable phenomenon that causes a decline in bodily functions over time. One of the most important processes that play a role in aging is senescence. Senescence is characterized by accumulation of cells that are no longer functional but elude the apoptotic pathway. These cells secrete inflammatory molecules that comprise the senescence associated secretory phenotype (SASP). Several essential molecules such as p53, Rb, and p16INK4a regulate the senescence process. Mitochondrial regulation has been found to play an important role in senescence. Reactive oxygen species (ROS) generated from mitochondria can affect cellular senescence by inducing the persistent DNA damage response, thus stabilizing the senescence. Evidently, senescence plays a major contributory role to the development of age-related neurological disorders. In this chapter, we discuss the role of senescence in the progression and onset of several neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Moreover, we also discuss the efficacy of certain molecules like MitoQ, SkQ1, and Latrepirdine that could be proven therapeutics with respect to these disorders by regulating mitochondrial activity.
Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

Giovanna Cenini,Ana Lloret,Roberta Cascella

DOI: https://doi.org/10.1155/2019/2105607

2019-05-09

Oxidative Medicine and Cellular Longevity

Abstract:Age is the main risk factor for a number of human diseases, including neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, which increasing numbers of elderly individuals suffer. These pathological conditions are characterized by progressive loss of neuron cells, compromised motor or cognitive functions, and accumulation of abnormally aggregated proteins. Mitochondrial dysfunction is one of the main features of the aging process, particularly in organs requiring a high-energy source such as the heart, muscles, brain, or liver. Neurons rely almost exclusively on the mitochondria, which produce the energy required for most of the cellular processes, including synaptic plasticity and neurotransmitter synthesis. The brain is particularly vulnerable to oxidative stress and damage, because of its high oxygen consumption, low antioxidant defenses, and high content of polyunsaturated fats very prone to be oxidized. Thus, it is not surprising the importance of protecting systems, including antioxidant defenses, to maintain neuronal integrity and survival. Here, we review the role of mitochondrial oxidative stress in the aging process, with a specific focus on neurodegenerative diseases. Understanding the molecular mechanisms involving mitochondria and oxidative stress in the aging and neurodegeneration may help to identify new strategies for improving the health and extending lifespan.

cell biology
Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions

Ying-ying Gu,Xin-ru Zhao,Nan Zhang,Yuan Yang,Ying Yi,Qian-hang Shao,Ming-xuan Liu,Xiao-ling Zhang

DOI: https://doi.org/10.1016/j.arr.2024.102577

IF: 11.788

2024-11-13

Ageing Research Reviews

Abstract:Neurodegenerative diseases, as common diseases in the elderly, tend to become younger due to environmental changes, social development and other factors. They are mainly characterized by progressive loss or dysfunction of neurons in the central or peripheral nervous system, and common diseases include Parkinson's disease, Alzheimer's disease, Huntington's disease and so on. Mitochondria are important organelles for adenosine triphosphate (ATP) production in the brain. In recent years, a large amount of evidence has shown that mitochondrial dysfunction plays a direct role in neurodegenerative diseases, which is expected to provide new ideas for the treatment of related diseases. This review will summarize the main mechanisms of mitochondrial dysfunction in neurodegenerative diseases, as well as collating recent advances in the study of mitochondrial disorders and new therapies.

cell biology,geriatrics & gerontology,gerontology
Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases

Xinnan Li,Longjian Huang,Jiaqi Lan,Xinhong Feng,Pingping Li,Lei Wu,Ying Peng

DOI: https://doi.org/10.1016/j.phrs.2020.105240

IF: 10.334

2021-01-01

Pharmacological Research

Abstract:<p>Neurodegenerative diseases are the most common diseases of the nervous system in elderly people, which are currently incurable and cause great burden to families and societies. Mitochondria are the energy factory of the cell and have extremely important effects on neuronal function. The elimination of dysfunctional mitochondria is essential for the mitochondrial metabolic homeostasis, energy supply, and neuronal survival. Recent studies suggest that the impaired mitophagy may lead to the accumulation of damaged mitochondria and therefore contribute to the progression of neurodegenerative diseases. This review mainly focuses on mitophagy, mitochondrial dynamics, and their abnormal changes in neurodegenerative diseases, as well as the therapeutic strategies targeting mitophagy that have shown promise in recent preclinical and clinical studies.</p>

pharmacology & pharmacy
Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases

Isaac G. Onyango,James P. Bennett,Gorazd B. Stokin,IsaacG Onyango,JamesP Bennett,GorazdB Stokin

DOI: https://doi.org/10.4103/1673-5374.303007

2021-01-01

Neural Regeneration Research

Abstract:Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are a heterogeneous group of debilitating disorders with multifactorial etiologies and pathogeneses that manifest distinct molecular mechanisms and clinical manifestations with abnormal protein dynamics and impaired bioenergetics. Mitochondrial dysfunction is emerging as an important feature in the etiopathogenesis of these age-related neurodegenerative diseases. The prevalence and incidence of these diseases is on the rise with the increasing global population and average lifespan. Although many therapeutic approaches have been tested, there are currently no effective treatment routes for the prevention or cure of these diseases. We present the current status of our knowledge and understanding of the involvement of mitochondrial dysfunction in these diseases and highlight recent advances in novel therapeutic strategies targeting neuronal bioenergetics as potential approach for treating these diseases.

neurosciences,cell biology
Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress

Anamaria Jurcau

DOI: https://doi.org/10.3390/ijms222111847

IF: 5.6

2021-10-31

International Journal of Molecular Sciences

Abstract:As the population ages, the incidence of neurodegenerative diseases is increasing. Due to intensive research, important steps in the elucidation of pathogenetic cascades have been made and significantly implicated mitochondrial dysfunction and oxidative stress. However, the available treatment in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis is mainly symptomatic, providing minor benefits and, at most, slowing down the progression of the disease. Although in preclinical setting, drugs targeting mitochondrial dysfunction and oxidative stress yielded encouraging results, clinical trials failed or had inconclusive results. It is likely that by the time of clinical diagnosis, the pathogenetic cascades are full-blown and significant numbers of neurons have already degenerated, making it impossible for mitochondria-targeted or antioxidant molecules to stop or reverse the process. Until further research will provide more efficient molecules, a healthy lifestyle, with plenty of dietary antioxidants and avoidance of exogenous oxidants may postpone the onset of neurodegeneration, while familial cases may benefit from genetic testing and aggressive therapy started in the preclinical stage.

biochemistry & molecular biology,chemistry, multidisciplinary

[A case of preauricular and cervical lymphadenitis due to Mycobacterium intracellulare].

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging

Rapid induction of hypothalamic iodothyronine deiodinase expression by photoperiod and melatonin in juvenile Siberian hamsters (Phodopus sungorus).

Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment

Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases

Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease

Species differences in the changes in heart rate and T-wave amplitude after autonomic blockade in Thoroughbred horses, ponies, cows, pigs, goats and chickens.

Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology

Alleviating Neurodegenerative Diseases Associated with Mitochondrial Defects by Therapeutic Biomolecules

Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases

Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets

Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation

Mitochondrial Dynamics: A Key Role in Neurodegeneration and a Potential Target for Neurodegenerative Disease

Clinical and morphometric observations on prostate cancer.

Targeting mitochondrial dysfunction to salvage cellular senescence for managing neurodegeneration

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions

Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases

Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases

Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress